Clinical Trial Detail

NCT ID NCT02589145
Title Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

diffuse large B-cell lymphoma

Therapies

Lenalidomide

Pyridoxine

Dexamethasone

Busulfan + Melphalan

Enoxaparin

Rituximab

Gemcitabine

Vorinostat

Palifermin

Age Groups:

No variant requirements are available.